MetLife (MET) Misses Q3 EPS by 11c, Revenue Beats
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $95.50 -2.17%
Revenue Growth %: +15.8%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q3 EPS of $1.21, $0.11 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $23.69 billion versus the consensus estimate of $18.33 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- BMO Capital Starts Lululemon (LULU) at Underperform
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
